Ego Pharmaceuticals is proud to announce our partnership with Wounds Australia, the peak national health body dedicated to the prevention, treatment, management, and healing of wounds.

Each year, more than 450,000 Australians are affected by a wound. This partnership allows Ego to contribute to enhancing skin integrity management reducing wound-related harm through supporting initiatives that promote better wound care.

Wounds Australia strives to ensure patients receive the highest quality wound care possible. They aim to prevent chronic wounds from occurring, thereby minimising unnecessary suffering and expense. Their mission is to reduce the harm caused by wounds by raising awareness, sharing knowledge, and establishing best practice guidelines.

Jeff Antcliff, CEO of Wounds Australia, commented on the collaboration, stating: "Skin integrity plays a big part in wound care and we are delighted to partner with a respected leader in skincare science. Through our educational efforts and Ego Pharmaceuticals' innovation, we hope to support healthcare professionals as they work to improve wound care outcomes. We look forward to a fruitful collaboration."

Ego Pharmaceuticals' Hospital & Aged Care Manager, Sharon Meere, added: "We're proud to partner with Wounds Australia to enhance skin integrity management in Australia. This collaboration aligns with our commitment to advancing skin and wound health through our science-backed products. We look forward to supporting Wounds Australia and healthcare professionals as we strive towards our common goal of improving skin integrity outcomes."

To learn more about the vital work of Wounds Australia, please visit their website.